Financial Snapshot

Revenue
$6.350M
TTM
Gross Margin
148.82%
TTM
Net Earnings
-$8.324M
TTM
Current Assets
Q4 2024
Current Liabilities
Q4 2024
Current Ratio
170.88%
Q4 2024
Total Assets
Q4 2024
Total Liabilities
$8.094M
Q4 2024
Book Value
$10.26M
Q4 2024
Cash
Q4 2024
P/E
-2.660
Apr 09, 2025 EST
Free Cash Flow
-$12.32M
TTM

Revenues

Revenues

Revenue YoY Change

Revenues

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Revenue $2.031M $8.548M $19.28M $13.98M $30.11M $25.07M $15.28M $12.50M $14.03M $19.12M $19.40M $15.33M $53.07M $33.49M $31.59M $24.46M $28.54M $35.64M $22.32M $28.57M $13.85M $11.84M $7.190M $6.520M $3.160M $90.00K $0.00
YoY Change -76.24% -55.67% 37.96% -53.58% 20.09% 64.15% 22.2% -10.87% -26.66% -1.43% 26.59% -71.12% 58.48% 6.01% 29.15% -14.3% -19.92% 59.68% -21.88% 106.28% 16.98% 64.67% 10.28% 106.33% 3411.11%

Expenses

Cost Of Revenues

Gross Profit

Gross Profit Margin

Gross Profit

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Revenue $2.031M $8.548M $19.28M $13.98M $30.11M $25.07M $15.28M $12.50M $14.03M $19.12M $19.40M $15.33M $53.07M $33.49M $31.59M $24.46M $28.54M $35.64M $22.32M $28.57M $13.85M $11.84M $7.190M $6.520M $3.160M $90.00K $0.00
Cost Of Revenue $78.00K $1.717M $1.588M $1.955M $1.406M $1.263M $1.640M $6.633M $5.290M $3.905M $5.686M $4.837M $4.654M $4.713M $4.280M $5.310M $3.370M $3.230M $3.250M $2.820M $2.730M $2.430M $3.090M $3.250M $1.880M $40.00K $0.00
Gross Profit $1.953M $6.831M $17.70M $12.02M $28.71M $23.81M $13.64M $5.867M $8.735M $15.22M $13.72M $10.49M $48.42M $28.77M $27.32M $19.15M $25.17M $32.41M $19.07M $25.75M $11.12M $9.410M $4.100M $3.270M $1.280M $50.00K $0.00
Gross Profit Margin 96.16% 79.91% 91.76% 86.01% 95.33% 94.96% 89.26% 46.94% 62.28% 79.58% 70.69% 68.44% 91.23% 85.93% 86.48% 78.29% 88.19% 90.94% 85.44% 90.13% 80.29% 79.48% 57.02% 50.15% 40.51% 55.56%

Selling, General & Admin Expense

Research & Development

Depreciation, Depletion & Amortization

SGA Expense to Gross Profit Ratio

R&D To Gross Profit Ratio

DDA To Gross Profit Ratio

Operating Expenses Total

Operating Profits/Loss

Operating Profits/Loss YoY Change

Operating Earnings to Gross Profit Ratio

Operating Profit Margin

Operational Expenses

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Selling, General & Admin $10.48M $14.36M $15.92M $14.45M $13.61M $14.12M $12.26M $13.17M $11.83M $11.57M $12.28M $12.71M $12.10M $13.57M $14.94M $15.02M $15.51M $13.65M $12.84M $11.03M $9.790M $8.400M $12.17M $12.23M $9.920M $2.970M $730.0K
YoY Change -27.03% -9.75% 10.15% 6.16% -3.57% 15.11% -6.86% 11.33% 2.24% -5.85% -3.32% 5.05% -10.9% -9.12% -0.55% -3.16% 13.63% 6.31% 16.41% 12.67% 16.55% -30.98% -0.49% 23.29% 234.01% 306.85%
% of Gross Profit 536.71% 210.28% 89.94% 120.19% 47.42% 59.28% 89.93% 224.39% 135.37% 76.0% 89.57% 121.14% 24.98% 47.17% 54.67% 78.43% 61.62% 42.12% 67.33% 42.83% 88.04% 89.27% 296.83% 374.01% 775.0% 5940.0%
Research & Development $10.38M $29.35M $36.86M $31.85M $27.71M $29.64M $25.01M $31.61M $29.27M $24.32M $22.43M $18.95M $20.27M $34.05M $36.21M $34.80M $40.85M $43.30M $37.67M $29.14M $24.39M $20.95M $29.55M $24.57M $13.34M $6.360M $710.0K
YoY Change -64.62% -20.38% 15.75% 14.93% -6.51% 18.5% -20.87% 7.98% 20.38% 8.42% 18.39% -6.51% -40.49% -5.96% 4.05% -14.81% -5.66% 14.95% 29.27% 19.48% 16.42% -29.1% 20.27% 84.18% 109.75% 795.77%
% of Gross Profit 531.64% 429.67% 208.32% 264.9% 96.53% 124.48% 183.45% 538.76% 335.13% 159.78% 163.54% 180.62% 41.86% 118.35% 132.54% 181.72% 162.3% 133.6% 197.54% 113.17% 219.33% 222.64% 720.73% 751.38% 1042.19% 12720.0%
Depreciation & Amortization $84.00K $31.00K $119.0K $288.0K $297.0K $291.0K $254.0K $437.0K $416.0K $425.0K $601.0K $558.0K $964.0K $1.176M $2.250M $2.510M $2.630M $2.320M $2.460M $3.170M $4.640M $4.740M $4.320M $3.290M $1.500M $310.0K $10.00K
YoY Change 170.97% -73.95% -58.68% -3.03% 2.06% 14.57% -41.88% 5.05% -2.12% -29.28% 7.71% -42.12% -18.03% -47.73% -10.36% -4.56% 13.36% -5.69% -22.4% -31.68% -2.11% 9.72% 31.31% 119.33% 383.87% 3000.0%
% of Gross Profit 4.3% 0.45% 0.67% 2.4% 1.03% 1.22% 1.86% 7.45% 4.76% 2.79% 4.38% 5.32% 1.99% 4.09% 8.24% 13.11% 10.45% 7.16% 12.9% 12.31% 41.73% 50.37% 105.37% 100.61% 117.19% 620.0%
Operating Expenses $20.87M $43.72M $52.78M $46.30M $41.32M $43.76M $37.28M $44.77M $41.10M $35.88M $34.71M $31.65M $32.36M $47.63M $14.94M $49.82M $56.35M $56.95M $50.50M $41.38M $35.43M $30.68M $43.06M $38.65M $24.10M $9.410M $1.440M
YoY Change -52.27% -17.17% 14.0% 12.04% -5.57% 17.38% -16.75% 8.94% 14.54% 3.37% 9.67% -2.19% -32.06% 218.85% -70.02% -11.59% -1.05% 12.77% 22.04% 16.79% 15.48% -28.75% 11.41% 60.37% 156.11% 553.47%
Operating Profit -$18.91M -$36.88M -$35.08M -$34.27M -$12.62M -$19.94M -$23.64M -$2.237M -$32.36M -$20.66M -$21.00M -$21.16M $16.06M -$18.85M $12.38M -$30.67M -$31.18M -$24.54M -$31.43M -$15.63M -$24.31M -$21.27M -$38.96M -$35.38M -$22.82M -$9.360M -$1.440M
YoY Change -48.73% 5.14% 2.36% 171.68% -36.75% -15.63% 956.77% -93.09% 56.62% -1.59% -0.77% -231.8% -185.16% -252.25% -140.37% -1.64% 27.06% -21.92% 101.09% -35.71% 14.29% -45.41% 10.12% 55.04% 143.8% 550.0%
Operating Profit To Gross Profit -968.36% -539.95% -198.26% -285.09% -43.95% -83.76% -173.38% -38.13% -370.51% -135.78% -153.1% -201.75% 33.16% -65.52% 45.33% -160.16% -123.88% -75.72% -164.81% -60.7% -218.62% -226.04% -950.24% -1081.96% -1782.81% -18720.0%
Operating Profit To Revenue -931.17% -431.49% -181.93% -245.21% -41.89% -79.54% -154.76% -17.9% -230.76% -108.05% -108.23% -138.08% 30.25% -56.3% 39.2% -125.39% -109.25% -68.86% -140.82% -54.71% -175.52% -179.65% -541.86% -542.64% -722.15% -10400.0%

Interest Expenses

Interest Expenses To Operating Income %

Other Expense/Income

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Interest Expense $821.0K -$663.0K $2.399M $2.148M $2.237M $2.501M $2.573M $2.425M $2.288M $2.236M $1.151M $6.000K $7.000K $5.000K $940.0K $380.0K $760.0K $920.0K $400.0K -$2.090M -$3.310M -$1.420M $1.800M $4.470M $2.970M $650.0K $120.0K
YoY Change -223.83% -127.64% 11.69% -3.98% -10.56% -2.8% 6.1% 5.99% 2.33% 94.27% 19083.33% -14.29% 40.0% -99.47% 147.37% -50.0% -17.39% 130.0% -119.14% -36.86% 133.1% -178.89% -59.73% 50.51% 356.92% 441.67%
% of Operating Profit 0.04% 7.59%
Other Income/Expense, Net $498.0K $9.923M -$251.0K -$1.992M -$1.720M -$1.427M -$1.703M -$1.458M -$2.145M -$1.999M -$1.112M -$290.0K $144.0K $88.00K
YoY Change -94.98% -4053.39% -87.4% 15.81% 20.53% -16.21% 16.8% -32.03% 7.3% 79.77% 283.45% -301.39% 63.64%

Income/Loss

Pretax Income

Income Tax

Net Profits/Loss

Pretax Income YoY Change

Income Tax Rate

Net Profits/Loss YoY Change

Basic EPS

Net Income To Revenue Ratio

Pretax & Net Income

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Pretax Income -$18.41M -$27.62M -$35.33M -$36.27M -$14.34M -$21.37M -$25.34M -$3.700M -$34.51M -$22.66M -$22.11M -$21.45M $16.20M -$18.77M -$22.90M -$30.29M -$43.91M -$24.34M -$33.33M -$18.12M -$27.62M -$22.70M -$37.17M -$44.93M -$19.85M -$8.710M -$1.320M
YoY Change -33.34% -21.82% -2.57% 152.89% -32.9% -15.67% 584.86% -89.28% 52.29% 2.49% 3.08% -232.41% -186.31% -18.03% -24.4% -31.02% 80.4% -26.97% 83.94% -34.4% 21.67% -38.93% -17.27% 126.35% 127.9% 559.85%
Income Tax $0.00 $0.00 $0.00 $0.00 -$150.0K $0.00 $53.00K $24.00K $320.0K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $20.00K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$8.324M -$27.62M -$35.33M -$36.27M -$582.0K -$20.58M -$25.32M -$3.695M -$34.51M -$22.66M -$22.11M -$21.45M $16.20M -$18.77M -$22.90M -$30.29M -$43.91M -$24.34M -$33.33M -$18.13M -$27.64M -$22.70M -$37.17M -$44.93M -$19.85M -$8.710M -$1.320M
YoY Change -69.87% -21.82% -2.57% 6131.1% -97.17% -18.73% 585.3% -89.29% 52.27% 2.5% 3.07% -232.42% -186.33% -18.06% -24.4% -31.02% 80.4% -26.97% 83.84% -34.41% 21.76% -38.93% -17.27% 126.35% 127.9% 559.85%
Net Earnings / Revenue -409.85% -323.16% -183.23% -259.46% -1.93% -82.07% -165.77% -29.56% -246.05% -118.51% -113.96% -139.97% 30.53% -56.04% -72.49% -123.83% -153.85% -68.29% -149.33% -63.46% -199.57% -191.72% -516.97% -689.11% -628.16% -9677.78%
Basic Earnings Per Share -$0.27 -$1.05 -$1.55 -$0.16 $0.00 -$0.12 -$0.16 -$0.03 -$0.26 -$0.19 -$0.20 -$0.21 $0.18 -$0.21
Diluted Earnings Per Share -$0.27 -$1.05 -$1.55 -$0.16 $0.00 -$0.12 -$0.16 -$0.03 -$0.26 -$0.19 -$0.20 -$0.21 $0.18 -$0.21 -$263.6K -$363.1K -$560.6K -$345.3K -$505.3K -$337.5K -$536.6K -$449.4K -$769.2K -$968.1K -$1.159M -$1.647M -$360.7K

Assets & Liabilities

Cash & Short-Term Investments

Cash & Equivalents

Cash To Operating Expenses Ratio

Inventory

Receivables

Total Short-Term Assets

Property, Plant And Equipment

Long-Term Investments

Total Long-Term Assets

Total Assets

Net Income To Total Assets Percentage

Accounts Payable

Short-Term Debt

Long Term Debt Due

Total Short-Term Liabilities

Long-Term Debt

Other Long-Term Liabilities

Total Long-Term Liabilities

Total Liabilities

Short-Term To Long-Term Debt Ratio

Short-Term Assets To Debt Ratio

Long-Term Debt To Net Income Ratio

Assets & Liabilities

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Cash & Short-Term Investments $11.80M $29.68M $43.48M $69.81M $40.70M $64.70M $34.30M $36.80M $25.00M $29.00M $32.70M $20.60M $28.50M $28.40M $45.40M $41.10M $50.30M $57.30M $69.90M $83.60M $41.80M $60.70M $42.80M $55.20M $104.4M $16.60M $8.000M
YoY Change -60.23% -31.74% -37.71% 71.52% -37.09% 88.63% -6.79% 47.2% -13.79% -11.31% 58.74% -27.72% 0.35% -37.44% 10.46% -18.29% -12.22% -18.03% -16.39% 100.0% -31.14% 41.82% -22.46% -47.13% 528.92% 107.5%
Cash & Equivalents $11.01M $28.40M $43.48M $49.84M $21.30M $34.90M $31.60M $29.40M $5.400M $3.600M $2.700M $7.800M $11.20M $8.900M $10.40M $8.300M $29.40M $37.60M $41.60M $65.50M $20.00M $21.20M $14.10M $12.60M $46.70M $3.900M $8.000M
Short-Term Investments $792.0K $1.280M $0.00 $19.97M $19.40M $29.80M $2.700M $7.400M $19.60M $25.50M $30.00M $12.80M $17.30M $19.50M $35.00M $32.80M $20.80M $19.70M $28.30M $18.00M $21.80M $39.50M $28.70M $42.60M $57.70M $12.70M $0.00
Other Short-Term Assets $813.0K $1.511M $2.375M $3.580M $19.50M $1.500M $2.200M $3.100M $2.500M $3.100M $1.000M $1.900M $2.300M $2.200M $2.900M $1.400M $2.500M $1.900M $1.700M $4.000M $1.400M $1.500M $1.600M $2.300M $900.0K $600.0K $100.0K
YoY Change -46.19% -36.38% -33.66% -81.64% 1200.0% -31.82% -29.03% 24.0% -19.35% 210.0% -47.37% -17.39% 4.55% -24.14% 107.14% -44.0% 31.58% 11.76% -57.5% 185.71% -6.67% -6.25% -30.43% 155.56% 50.0% 500.0%
Inventory $106.0K $2.219M $2.113M $1.870M $1.900M $3.400M $3.400M $3.200M $3.800M $3.900M $3.600M $3.500M $3.400M $3.300M $2.800M $2.800M $3.500M $2.000M $2.100M $2.000M $1.900M $1.900M $1.700M $1.900M $2.700M $200.0K $0.00
Prepaid Expenses
Receivables $453.0K $1.261M $3.423M $6.477M $900.0K $2.300M $1.800M $2.400M $1.200M $2.200M $2.100M $2.300M $2.200M $3.400M $3.700M $1.700M $4.100M $3.600M $2.200M $4.500M $2.500M $2.000M $900.0K $800.0K $1.300M $100.0K $0.00
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $13.18M $34.67M $51.39M $81.74M $63.10M $71.80M $41.70M $45.40M $32.40M $38.30M $39.50M $28.30M $36.40M $37.30M $54.80M $47.10M $60.30M $64.80M $75.80M $94.10M $47.60M $66.10M $47.00M $60.20M $109.3M $17.50M $8.100M
YoY Change -62.0% -32.54% -37.12% 29.54% -12.12% 72.18% -8.15% 40.12% -15.4% -3.04% 39.58% -22.25% -2.41% -31.93% 16.35% -21.89% -6.94% -14.51% -19.45% 97.69% -27.99% 40.64% -21.93% -44.92% 524.57% 116.05%
Property, Plant & Equipment $2.176M $4.071M $2.131M $3.673M $5.000M $6.500M $600.0K $900.0K $1.300M $1.600M $1.700M $2.000M $2.500M $3.100M $1.800M $3.800M $6.000M $7.700M $7.500M $7.300M $7.100M $9.300M $11.60M $13.10M $4.500M $1.300M $200.0K
YoY Change -46.55% 91.04% -41.98% -26.54% -23.08% 983.33% -33.33% -30.77% -18.75% -5.88% -15.0% -20.0% -19.35% 72.22% -52.63% -36.67% -22.08% 2.67% 2.74% 2.82% -23.66% -19.83% -11.45% 191.11% 246.15% 550.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $1.000M $0.00 $1.800M $3.400M $0.00 $1.500M $3.200M $0.00 $1.400M $3.700M $10.50M $5.500M $17.20M $21.30M $2.600M $18.00M $1.700M $2.300M $0.00
YoY Change -100.0% -100.0% -47.06% -100.0% -53.13% -100.0% -62.16% -64.76% 90.91% -68.02% -19.25% 719.23% -85.56% 958.82% -26.09%
Other Assets $273.0K $278.0K $406.0K $411.0K $400.0K $1.300M $1.300M $400.0K $400.0K $500.0K $600.0K $700.0K $700.0K $800.0K $1.300M $800.0K $700.0K $1.300M $2.300M $3.600M $5.400M $6.300M $2.900M $3.400M $0.00
YoY Change -1.8% -31.53% -1.22% 2.75% -69.23% 0.0% 225.0% 0.0% -20.0% -16.67% -14.29% 0.0% -12.5% -38.46% 62.5% 14.29% -46.15% -43.48% -36.11% -33.33% -14.29% 117.24% -14.71%
Total Long-Term Assets $5.174M $10.52M $8.706M $10.25M $12.50M $14.20M $8.300M $7.700M $8.100M $8.500M $10.60M $12.50M $9.500M $11.90M $12.80M $11.10M $14.60M $19.20M $26.70M $23.30M $37.90M $46.30M $26.00M $44.70M $11.30M $5.000M $200.0K
YoY Change -50.81% 20.81% -15.09% -17.98% -11.97% 71.08% 7.79% -4.94% -4.71% -19.81% -15.2% 31.58% -20.17% -7.03% 15.32% -23.97% -23.96% -28.09% 14.59% -38.52% -18.14% 78.08% -41.83% 295.58% 126.0% 2400.0%
Total Assets $18.35M $45.19M $60.10M $91.99M $75.60M $86.00M $50.00M $53.10M $40.50M $46.80M $50.10M $40.80M $45.90M $49.20M $67.60M $58.20M $74.90M $84.00M $102.5M $117.4M $85.50M $112.4M $73.00M $104.9M $120.6M $22.50M $8.300M
YoY Change
Accounts Payable $309.0K $1.777M $3.106M $1.311M $1.700M $2.100M $1.600M $1.500M $2.100M $1.300M $1.000M $700.0K $1.800M $1.300M $1.000M $1.000M $1.000M $1.800M $900.0K $1.800M $1.700M $600.0K $400.0K $2.000M $700.0K $500.0K $100.0K
YoY Change -82.61% -42.79% 136.92% -22.88% -19.05% 31.25% 6.67% -28.57% 61.54% 30.0% 42.86% -61.11% 38.46% 30.0% 0.0% 0.0% -44.44% 100.0% -50.0% 5.88% 183.33% 50.0% -80.0% 185.71% 40.0% 400.0%
Accrued Expenses $5.649M $5.769M $7.762M $8.550M $7.600M $8.300M $4.700M $5.500M $5.100M $5.000M $5.100M $5.900M $4.000M $4.900M $6.500M $5.300M $5.200M $5.500M $4.500M $3.900M $2.500M $2.600M $2.100M $2.400M $2.900M $800.0K $400.0K
YoY Change -2.08% -25.68% -9.22% 12.5% -8.43% 76.6% -14.55% 7.84% 2.0% -1.96% -13.56% 47.5% -18.37% -24.62% 22.64% 1.92% -5.45% 22.22% 15.38% 56.0% -3.85% 23.81% -12.5% -17.24% 262.5% 100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $16.66M $21.17M $0.00 $900.0K $0.00 $7.300M $19.90M $0.00 $23.60M $200.0K $200.0K $500.0K $500.0K $600.0K $700.0K $400.0K $100.0K $0.00
YoY Change -100.0% -21.29% -100.0% -100.0% -63.32% -100.0% 11700.0% 0.0% -60.0% 0.0% -16.67% -14.29% 75.0% 300.0%
Total Short-Term Liabilities $7.710M $27.01M $34.00M $10.06M $10.70M $36.80M $7.700M $15.80M $28.80M $7.400M $7.000M $7.200M $6.900M $14.90M $17.90M $12.30M $16.90M $39.10M $12.70M $9.900M $5.500M $5.000M $5.200M $5.700M $4.300M $1.500M $500.0K
YoY Change -71.46% -20.57% 238.15% -6.02% -70.92% 377.92% -51.27% -45.14% 289.19% 5.71% -2.78% 4.35% -53.69% -16.76% 45.53% -27.22% -56.78% 207.87% 28.28% 80.0% 10.0% -3.85% -8.77% 32.56% 186.67% 200.0%
Long-Term Debt $0.00 $0.00 $0.00 $20.63M $19.90M $20.30M $20.50M $12.60M $0.00 $19.70M $19.80M $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $37.90M $58.00M $60.90M $61.40M $1.400M $2.000M $1.100M $200.0K $100.0K
YoY Change -100.0% 3.68% -1.97% -0.98% 62.7% -100.0% -0.51% -100.0% -34.66% -4.76% -0.81% 4285.71% -30.0% 81.82% 450.0% 100.0%
Other Long-Term Liabilities $1.508M $3.395M $1.111M $3.520M $4.900M $6.100M $1.800M $3.200M $3.400M $4.800M $4.800M $2.900M $2.700M $30.80M $35.20M $18.10M $20.40M $10.40M $14.80M $6.100M $700.0K $900.0K $200.0K $200.0K $0.00 $0.00
YoY Change -55.58% 205.58% -68.44% -28.16% -19.67% 238.89% -43.75% -5.88% -29.17% 0.0% 65.52% 7.41% -91.23% -12.5% 94.48% -11.27% 96.15% -29.73% 142.62% 771.43% -22.22% 350.0% 0.0%
Total Long-Term Liabilities $1.508M $3.395M $1.111M $24.15M $24.80M $26.40M $22.30M $15.80M $3.400M $24.50M $24.60M $2.900M $2.700M $30.80M $35.20M $18.10M $20.40M $10.40M $52.70M $64.10M $61.60M $62.30M $1.600M $2.200M $1.100M $200.0K $100.0K
YoY Change -55.58% 205.58% -95.4% -2.61% -6.06% 18.39% 41.14% 364.71% -86.12% -0.41% 748.28% 7.41% -91.23% -12.5% 94.48% -11.27% 96.15% -80.27% -17.78% 4.06% -1.12% 3793.75% -27.27% 100.0% 450.0% 100.0%
Total Liabilities $9.218M $30.41M $35.12M $34.21M $35.50M $63.20M $30.00M $31.60M $32.20M $31.90M $31.60M $10.10M $9.600M $45.70M $53.10M $30.30M $37.30M $49.40M $65.50M $74.10M $67.10M $67.30M $6.800M $7.900M $5.400M $1.700M $500.0K
YoY Change -69.68% -13.41% 2.65% -3.64% -43.83% 110.67% -5.06% -1.86% 0.94% 0.95% 212.87% 5.21% -78.99% -13.94% 75.25% -18.77% -24.49% -24.58% -11.61% 10.43% -0.3% 889.71% -13.92% 46.3% 217.65% 240.0%

Ownership

Basic Shares Outstanding

Diluted Shares Outstanding

Preferred Stock

No data

Treasury Stock Shares

No data

Stock Issuance & Repurchase

Ownership Data

Concept 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998
Basic Shares Outstanding 30.94M 26.26M 22.78M 225.0M 199.5M 178.0M 159.8M 145.3M 133.2M 118.5M 111.7M 103.1M shares 88.43M shares 87.41M shares
Diluted Shares Outstanding 30.94M 26.52M 22.78M 22.51M 19.95M 159.8M 145.3M 133.2M 118.5M 111.7M 103.1M shares 88.59M shares 87.41M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Book Value

Free Cash Flow

Free Cash Flow YoY

Free Cash Flow Margin

Dividends

Dividends

No data

Stock Price

Market Cap: $22.145 Million

About DURECT CORP

DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. The company is headquartered in Cupertino, California and currently employs 45 full-time employees. The company went IPO on 2000-09-28. The firm is engaged in the development of epigenetic therapies that target dysregulated deoxyribonucleic acid (DNA) methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury. Its lead drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in alcoholic hepatitis (AH) patients. Larsucosterol is in clinical development for the potential treatment of AH, for which the FDA has granted a Fast Track and a Therapy designation, and metabolic dysfunction-associated steatohepatitis (MASH) is also being explored. Its commercial pharmaceutical product includes POSIMIR (bupivacaine solution) for infiltration use, a non-opioid analgesic utilizing the SABER platform technology. The company has also completed Alcohol-Associated Hepatitis (AHFIRM) Phase 2b study.

Industry: Pharmaceutical Preparations Peers: Lyra Therapeutics Inc CorMedix Inc. Ikena Oncology Inc Johnson & Johnson MariMed Inc Paratek Pharmaceuticals, Inc. scPharmaceuticals Inc TFF Pharmaceuticals, Inc. Verrica Pharmaceuticals Inc